SMN2 and proximal spinal muscular atrophy: The NURTURE study of nusinersen is a phase 2, multicentre, open-label, single-arm study which enrolled 25 babies with presymptomatic SMA, i.e., no clinical signs or symptoms of SMA (15 with two SMN2 copies and 10 with three SMN2 copies) [10,11].